• Vir Biotechnology (NASDAQ:VIR) Earns "Buy" Rating from Needham & Company LLC

    Source: Buzz FX / 01 Nov 2024 07:46:15   America/Chicago


    Vir Biotechnology (NASDAQ:VIR) Earns "Buy" Rating from Needham & Company LLC Written by MarketBeat November 1, 2024 Share Link copied to clipboard. Vir Biotechnology ( NASDAQ:VIR - Get Free Report ) 's stock had its "buy" rating reiterated
    Read more...
Share on,